Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
Open Access
- 2 November 2016
- journal article
- research article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2016, 1-7
- https://doi.org/10.1155/2016/8390210
Abstract
Introduction. Aim of this study is to determine if HbA1c levels are a reliable predictor of glycemic control in patients with decompensated cirrhosis.Methods. 200 unique patients referred for liver transplantation at University of Tennessee/Methodist University Transplant Institute with a HbA1c result were included. Three glucose levels prior to the “measured” A1c (MA1c) were input into an HbA1c calculator from the American Diabetes Association website to determine the “calculated” A1c (CA1c). The differences between MA1c and CA1c levels were computed. Patients were divided into three groups: group A, difference of 1.5.Results. 97 (49%) patients had hemoglobin A1c of less than 5%. Discordance between calculated and measured HbA1c of >0.5% was seen in 47% (). Higher level of discordance of greater than >1.5 was in 12% of patients (). Hemoglobin was an independent predictor for higher discordance (odds ratio 0.77 95%, CI 0.60–0.99, andvalue 0.04). HbA1c was an independent predictor of occurrence of HCC (OR 2.69 955, CI 1.38–5.43, andvalue 0.008).Conclusion. HbA1c is not a reliable predictor of glycemic control in patients with decompensated cirrhosis, especially in those with severe anemia.
Keywords
This publication has 53 references indexed in Scilit:
- Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese populationBMC Gastroenterology, 2013
- Low Glycated Hemoglobin and Liver Disease in the U.S. PopulationDiabetes Care, 2011
- Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes RegistryDiabetes, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- GHb Level and Subsequent Mortality Among Adults in the U.S.Diabetes Care, 2009
- Early Predictors of Anemia in Patients With Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a (40KD) Plus RibavirinThe American Journal of Gastroenterology, 2008
- Aplastic anemiaCurrent Opinion in Hematology, 2008
- Current concepts in the pathophysiology and treatment of aplastic anemiaBlood, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisJournal of Hepatology, 2006
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2005